These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9149644)

  • 1. Standardized forms to use in the management of HIV infection.
    Parra EO
    Am Fam Physician; 1997 May; 55(6):2166-72, 2182-4. PubMed ID: 9149644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for managing hepatitis C virus infection in HIV-infected patients.
    Clanon KA
    Top HIV Med; 2003; 11(2):50-4. PubMed ID: 12717042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary human immunodeficiency virus.
    Taiwo BO; Hicks CB
    South Med J; 2002 Nov; 95(11):1312-7. PubMed ID: 12539999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Asymptomatic patient in human immunodeficiency virus infection].
    Jacomet C; Girard PM
    Rev Prat; 1995 Mar; 45(6):715-21. PubMed ID: 7754309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caring for patients with HIV infection. Management plan for family physicians.
    Bally G
    Can Fam Physician; 1993 Oct; 39():2175-82. PubMed ID: 8219865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantification of viremia in patients infected with human immunodeficiency virus with different degrees of immunosuppression].
    Soriano V; Gómez-Cano M; Mas A; Villalba N; Castilla J; Adrados M; Laguna F; Polo R; González-Lahoz J
    Rev Clin Esp; 1997 Dec; 197(12):810-3. PubMed ID: 9477671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician specialization and the quality of care for human immunodeficiency virus infection.
    Landon BE; Wilson IB; McInnes K; Landrum MB; Hirschhorn LR; Marsden PV; Cleary PD
    Arch Intern Med; 2005 May; 165(10):1133-9. PubMed ID: 15911726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C; Lee S; Wong Kh; Cheng L; Lam M
    HIV Med; 2007 Apr; 8(3):181-5. PubMed ID: 17461862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3.
    Fillaux J; Delpierre C; Alvarez M; Jaafar A; Marchou B; Massip P; Cuzin L
    Med Mal Infect; 2006 Jun; 36(6):335-9. PubMed ID: 16631330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of physician specialty on counseling practices and medical referral patterns among physicians caring for disadvantaged human immunodeficiency virus-infected populations.
    Duffus WA; Barragan M; Metsch L; Krawczyk CS; Loughlin AM; Gardner LI; Anderson-Mahoney P; Dickinson G; del Rio C;
    Clin Infect Dis; 2003 Jun; 36(12):1577-84. PubMed ID: 12802759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
    Schreibman T; Friedland G
    Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.